...
【24h】

Portal venous gas following chemotherapy for colorectal cancer liver metastasis.

机译:化疗后门静脉血用于大肠癌肝转移。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The standard of care for patients with colorectal liver metastases is a combination of chemotherapy and surgery. New chemotherapy regimens with biologic agents (cetuximab, bevacizumab) have been shown to increase tumor response rates. Although this might be beneficial and this is an expected endpoint, it should be noted that patients with synchronous colorectal and liver metastases are at risk of septic complications. We recently encountered a case of hepatic portal venous gas after two cycles of chemotherapy in a patient with right colon cancer liver metastases. Complete necrosis of the liver metastasis subsequently turned into a liver abscess, which fistulized in the right portal vein. Infection of the necrotized metastasis was thought to be promoted by the colic tumor. Although this is a dramatic situation, it does not contraindicate a curative surgical resection.
机译:大肠肝转移患者的护理标准是化学疗法和手术疗法的结合。已经证明,使用生物制剂(西妥昔单抗,贝伐单抗)的新化学疗法可增加肿瘤反应率。尽管这可能是有益的,并且这是预期的终点,但应注意的是,同时发生大肠和肝转移的患者有感染性并发症的风险。我们最近在右结肠癌肝转移患者中进行了两个周期的化疗后,遇到一例肝门静脉血气。肝转移的完全坏死随后变成肝脓肿,其在右门静脉内瘘。坏死的转移瘤的感染被认为是由结肠肿瘤促进的。尽管这是一个戏剧性的情况,但它并不禁忌根治性手术切除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号